Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis

Synthetic cannabinoid receptor agonists (SCRAs) may be used as an alternative to natural cannabis; however, they may carry a greater risk of problematic use and withdrawal. This study aimed to characterise the withdrawal symptom profile of SCRAs and compare their profile of effect with high-potency...

Descripción completa

Detalles Bibliográficos
Autores principales: Craft, Sam, Ferris, Jason A., Barratt, Monica J., Maier, Larissa J., Lynskey, Michael T., Winstock, Adam R., Freeman, Tom P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110517/
https://www.ncbi.nlm.nih.gov/pubmed/34533608
http://dx.doi.org/10.1007/s00213-021-05945-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110517/
https://www.ncbi.nlm.nih.gov/pubmed/34533608
http://dx.doi.org/10.1007/s00213-021-05945-1

Ejemplares similares